3 New Strong Buy Ratings from Top-Rated Analysts: 08/12/2025

By Mijuško Šibalić, Stock Market Writer and Stock Researcher

August 12, 2025 5:54 AM UTC

3 New Strong Buy Ratings from Top-Rated Analysts: 08/12/2025

IDXX

MTZ

RAMP

Need some investing ideas? Here’s the latest from our popular Strong Buy Stocks from Top Wall Street Analysts screener:

Why analysts believe Liveramp (RAMP) could nearly double in the coming year
MasTec (MTZ) has an impressive backlog that could lead to long-term gains
Analysts have great confidence in Idexx Laboratories’ (IDXX) near-term growth prospects

P.S. Get more alerts like this daily … Try WallStreetZen Premium.

A note from our sponsors...

Sell Nvidia and replace it with WHAT?! The AI trade is running full throttle. But it won't last forever. It's not time to abandon AI stocks completely, but it IS time to prepare for the inevitable slowdown. Futurist Eric is giving away 7 free trade ideas in his "Sell This, Buy That" research package, where he reveals which market moves you need to make today (starting with getting rid of Nvidia stock.) Access these trade ideas here.

1. Idexx Laboratories (NASDAQ: IDXX)

Idexx Laboratories is a dominant player in veterinary diagnostics, software, and water testing — and currently operates in a whopping 175 countries. IDXX has rallied by 60.95% since the start of the year — the company recently delivered a double beat, and its impressive balance sheet is more than enough to support further growth.

Zen Rating: B (Buy) — see full analysis >

Recent Price: $658.06 — get current quote >

Max 1-year forecast: $675.00

Why we’re watching:

IDXX shares currently have 2 Strong Buy ratings, 1 Buy rating, and 3 Hold ratings. See the ratings
Chris Schott of JP Morgan (a top 23% rated analyst) doubled down on a Strong Buy rating on the stock following the company’s Q2 2025 earnings and hiked his price target from $550 to a Street-high $675.
In general, the print was positive, with results above expectations, InVue Dx's launch getting off to a promising start, and management raising its 2025 guidance, Schott told readers.
Although unfavorable investor positioning is impacting the stock's post-print momentum, the analyst said they increased their estimates because of greater confidence in Idexx Laboratories' new launch trends and near-term growth guidance.
Schott added that they remain satisfied that the company can achieve long-term sustainable growth in the double digits.
Idexx Laboratories stock ranks in the top 9% of the equities we track, giving it a Zen Rating of B, which corresponds to an average annual return of 19.88%.
Our Safety Component Grade rating is a measure of stock price stability, revenue inflow stability, and how predictable a ticker’s earnings are. In this regard, IDXX ranks in the top 20% of equities.
A stock’s Artificial Intelligence rating is derived from the findings of a neural network trained on two decades of market data. In this category, Idexx Laboratories shares rank in the top 19%.
However, Financials are the star of the show — as IDXX ranks in the 98th percentile of equities in terms of its balance sheet. (See all 7 Zen Component Grades here >)

2. MasTec (NYSE: MTZ)

MasTec is an infrastructure construction business — but there’s an important twist. The business specializes in electrical transmission networks, 5G deployment, and renewable energy infrastructure. More recently, it has also expanded into data centers. Per a recent earnings report, our latest pick also has a record-breaking $15.9 billion backlog. However, it is the MTZ’s growth potential going forward that makes it worth a closer look.

Zen Rating: A (Strong Buy) — see full analysis >

Recent Price: $181.30 — get current quote >

Max 1-year forecast: $227.00

Why we’re watching:

MTZ enjoys broad, nearly unanimous bullish support from Wall Street equity researchers. The stock currently has 14 Strong Buy ratings and 1 Hold rating. See the ratings
Following the company’s Q2 2025 earnings call, Citigroup researcher Andy Kaplowitz (a top 1% rated analyst) reiterated a Strong Buy rating on the stock and adjusted his price forecast from $220 to $219.
Noting that the quarter beat on earnings and management raised its FY 2025 guidance, Kaplowitz called the post-print selloff "somewhat overdone."
MasTec is currently the 7th highest-rated stock in the Engineering & Construction industry, which has an Industry Rating of A.
MTZ ranks in the 96th percentile of the equities that our system tracks, giving it a Zen Rating of A.
There’s plenty to like here — for instance, the stock ranks in the top 14% when it comes to both Sentiment and Safety.
MasTec shares have rallied by 29.51% since the start of the year, and rank in the 89th percentile in terms of Momentum.
Growth, however, is MTZ’s strongest suit — in this category, the stock ranks in the top 1% of the equities that we track. (See all 7 Zen Component Grades here >)

3. Liveramp (NYSE: RAMP)

LiveRamp isn’t just a crucial data connectivity provider — it’s a previous holding in the market-beating Zen Investor portfolio. In an era where data security is becoming a top priority, RAMP has seen stellar returns on account of its proven business model. The company recently delivered a double beat, but the stock has dropped on account of profit-taking — so it’s currently trading at a discount.

Zen Rating: A (Strong Buy) — see full analysis >

Recent Price: $26.46 — get current quote >

Max 1-year forecast: $53.00

Why we’re watching:

RAMP shares are covered by 4 Wall Street analysts — their coverage is split between 2 Strong Buy ratings and 2 Hold ratings. See the ratings
However, the average price target for LiveRamp stock, currently pegged at $40.75, implies a hefty 54.01% upside.
Benchmark researcher Mark Zgutowicz (a top 15% rated analyst) maintained a Strong Buy rating on RAMP following the company’s Q1 2026 earnings call, and increased his price target from $51 to a Street-high $53.
Zgutowicz highlighted that the quarter delivered subscription revenue and operating income beats.
Looking ahead, the analyst told readers that management is sure the launch of its new pricing model last month, which will transition the company from a generally high-fixed pricing model to a lower cost-based usage model, will produce "many more wins" in the Commerce Media sector.
LiveRamp is currently the 4th highest-rated stock in the Software Infrastructure industry, which has an Industry Rating of A.
Our quant rating system, Zen Ratings, uses 115 proprietary factors to evaluate stocks. It puts RAMP in the top 3% of stocks, giving it a Zen Rating of A — stocks with this distinction have, on average, provided an annual return of 32.52% since the early 2000s.
Each Zen Rating is a composite of seven Component Grade ratings. For instance, LiveRamp scores highly in two categories — Value and Growth.
When it comes to Value, RAMP is trading at a price-to-earnings growth (PEG) ratio of just 0.67x — so it’s no wonder that it ranks in the 92nd percentile in this category.
However, Growth is the main selling point here — LiveRamp shares rank in the top 2% of the more than 4,600 equities that we track in this regard. (See all 7 Zen Component Grades here >)